サマリー

Ketorolac Injectionの世界市場は、2020年に967.04百万米ドルと評価され、2021-2027年の間に2.69%のCAGRで成長し、2027年末には1102.17百万米ドルに達すると予想されています。
当レポートでは、世界レベル、地域レベル、企業レベルでのKetorolac Injectionの数量と価値に焦点を当てています。世界的な観点から、本レポートは過去のデータと将来の展望を分析することで、Ketorolac Injectionの全体的な市場規模を表しています。地域的には、本レポートはいくつかの主要地域に焦点を当てています。北米、欧州、中国、インド、など。
Ketorolac（ケトロラック）注射剤の世界市場。セグメント分析
この調査レポートでは、地域（国）別、企業別、タイプ別、アプリケーション別の具体的なセグメントを紹介しています。本調査では、2016年から2027年までの歴史的期間および予測期間における売上と収益に関する情報を提供しています。セグメントを理解することで、市場の成長を助けるさまざまな要因の重要性を見極めることができます。
企業別
ファイザー
フレゼニウス・カビ
フォスン・ファーマ（グランド・ファーマ）
サージェント・ファーマシューティカルズ
ヒグマ
ルナン・ファーム
アルボゲン
成都ブリリアント製薬
アテネクス
四川Medcalo
ジュルファー・バングラデシュ社
Yung Shin Pharm
天津チェイスサン製薬
ZISKA Pharmaceuticalshin Pharm
タイプ別セグメント
15mg/ml
30mg/ml
用途別セグメント
病院
クリニック
その他
地域別
北アメリカ
アメリカ
カナダ

アジアパシフィック
中国
日本
韓国
インド
オーストラリア
東南アジア

ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア

ラテンアメリカ
メキシコ
ブラジル
アルゼンチン

中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦

ページTOPに戻る

目次

1 KETOROLAC INJECTION MARKET OVERVIEW 1
1.1 Product Overview and Scope of Ketorolac Injection 1
1.2 Ketorolac Injection Segment by Type 1
1.2.1 Global Ketorolac Injection Sales Growth Rate Comparison by Type (2021-2027) 1
1.2.2 15mg/ml 2
1.2.3 30mg/ml 2
1.3 Ketorolac Injection Segment by Application 3
1.3.1 Global Ketorolac Injection Sales Comparison by Application (2021-2027) 3
1.3.2 Hospital 4
1.3.3 Clinics 5
1.3.4 Others 5
1.4 Global Ketorolac Injection Market Size Estimates and Forecasts 5
1.4.1 Global Ketorolac Injection Revenue 2016-2027 5
1.4.2 Global Ketorolac Injection Sales 2016-2027 7
1.4.3 Ketorolac Injection Market Size by Region: 2016 Versus 2021 Versus 2027 7
2 KETOROLAC INJECTION MARKET COMPETITION BY MANUFACTURERS 9
2.1 Global Ketorolac Injection Sales Market Share by Manufacturers (2016-2021) 9
2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2016-2021) 11
2.3 Global Ketorolac Injection Average Price by Manufacturers (2016-2021) 13
2.4 Manufacturers Ketorolac Injection Manufacturing Sites, Area Served, Product Type 14
2.5 Ketorolac Injection Market Competitive Situation and Trends 15
2.5.1 Ketorolac Injection Market Concentration Rate 15
2.5.2 The Global 5 and 10 Largest Ketorolac Injection Players Market Share by Revenue 16
2.5.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 16
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 17
3 KETOROLAC INJECTION RETROSPECTIVE MARKET SCENARIO BY REGION 19
3.1 Global Ketorolac Injection Retrospective Market Scenario in Sales by Region: 2016-2021 19
3.2 Global Ketorolac Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 20
3.3 North America Ketorolac Injection Market Facts & Figures by Country 22
3.3.1 North America Ketorolac Injection Sales by Country 22
3.3.2 North America Ketorolac Injection Revenue by Country 23
3.3.3 U.S. 23
3.3.4 Canada 24
3.4 Europe Ketorolac Injection Market Facts & Figures by Country 24
3.4.1 Europe Ketorolac Injection Sales by Country 24
3.4.2 Europe Ketorolac Injection Revenue by Country 25
3.4.3 Germany 26
3.4.4 France 26
3.4.5 U.K. 27
3.4.6 Italy 27
3.4.7 Russia 28
3.5 Asia Pacific Ketorolac Injection Market Facts & Figures by Region 28
3.5.1 Asia Pacific Ketorolac Injection Sales by Region 28
3.5.2 Asia Pacific Ketorolac Injection Revenue by Region 29
3.5.3 China 30
3.5.4 Japan 30
3.5.5 South Korea 31
3.5.6 India 31
3.5.7 Australia 32
3.5.8 Southeast Asia 32
3.6 Latin America Ketorolac Injection Market Facts & Figures by Country 33
3.6.1 Latin America Ketorolac Injection Sales by Country 33
3.6.2 Latin America Ketorolac Injection Revenue by Country 33
3.6.3 Mexico 34
3.6.4 Brazil 34
3.6.5 Argentina 35
3.7 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country 35
3.7.1 Middle East and Africa Ketorolac Injection Sales by Country 35
3.7.2 Middle East and Africa Ketorolac Injection Revenue by Country 36
3.7.3 Turkey 37
3.7.4 Saudi Arabia 37
3.7.5 UAE 38
4 KETOROLAC INJECTION HISTORIC MARKET ANALYSIS BY TYPE 39
4.1 Global Ketorolac Injection Sales Market Share by Type (2016-2021) 39
4.2 Global Ketorolac Injection Revenue Market Share by Type (2016-2021) 40
4.3 Global Ketorolac Injection Price by Type (2016-2021) 40
5 KETOROLAC INJECTION HISTORIC MARKET ANALYSIS BY APPLICATION 41
5.1 Global Ketorolac Injection Sales Market Share by Application (2016-2021) 41
5.2 Global Ketorolac Injection Revenue Market Share by Application (2016-2021) 42
5.3 Global Ketorolac Injection Price by Application (2016-2021) 43
6 KEY COMPANIES PROFILED 45
6.1 Pfizer 45
6.1.1 Pfizer Corporation Information 45
6.1.2 Pfizer Description and Business Overview 45
6.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 46
6.1.4 Pfizer Ketorolac Injection Product Portfolio 46
6.1.5 Pfizer Recent Developments/Updates 46
6.2 Fresenius Kabi 47
6.2.1 Fresenius Kabi Corporation Information 47
6.2.2 Fresenius Kabi Description and Business Overview 47
6.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 48
6.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio 49
6.2.5 Fresenius Kabi Recent Developments/Updates 49
6.3 Fosun Pharma (Gland Pharma) 49
6.3.1 Fosun Pharma (Gland Pharma) Corporation Information 49
6.3.2 Fosun Pharma (Gland Pharma) Description and Business Overview 50
6.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 51
6.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio 51
6.3.5 Fosun Pharma (Gland Pharma) Recent Developments/Updates 51
6.4 Sagent Pharmaceuticals 52
6.4.1 Sagent Pharmaceuticals Corporation Information 52
6.4.2 Sagent Pharmaceuticals Description and Business Overview 52
6.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 52
6.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio 53
6.4.5 Sagent Pharmaceuticals Recent Developments/Updates 53
6.5 Hikma 53
6.5.1 Hikma Corporation Information 53
6.5.2 Hikma Description and Business Overview 54
6.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 54
6.5.4 Hikma Ketorolac Injection Product Portfolio 55
6.5.5 Hikma Recent Developments/Updates 55
6.6 Lunan Pharma 55
6.6.1 Lunan Pharma Corporation Information 55
6.6.2 Lunan Pharma Description and Business Overview 56
6.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 56
6.6.4 Lunan Pharma Ketorolac Injection Product Portfolio 57
6.7 Alvogen 57
6.7.1 Alvogen Corporation Information 57
6.7.2 Alvogen Description and Business Overview 58
6.7.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 58
6.7.4 Alvogen Ketorolac Injection Product Portfolio 58
6.7.5 Alvogen Recent Developments/Updates 59
6.8 Chengdu Brilliant Pharmaceuticals 59
6.8.1 Chengdu Brilliant Pharmaceuticals Corporation Information 59
6.8.2 Chengdu Brilliant Pharmaceuticals Description and Business Overview 60
6.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 60
6.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio 60
6.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates 61
6.9 Athenex 61
6.9.1 Athenex Corporation Information 61
6.9.2 Athenex Description and Business Overview 62
6.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 62
6.9.4 Athenex Ketorolac Injection Product Portfolio 62
6.9.5 Athenex Recent Developments/Updates 63
6.10 Sichuan Medcalo 63
6.10.1 Sichuan Medcalo Corporation Information 63
6.10.2 Sichuan Medcalo Description and Business Overview 63
6.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 64
6.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio 65
6.10.5 Sichuan Medcalo Recent Developments/Updates 65
6.11 Julphar Bangladesh Ltd. 65
6.11.1 Julphar Bangladesh Ltd. Corporation Information 65
6.11.2 Julphar Bangladesh Ltd. Description and Business Overview 66
6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 66
6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio 67
6.12 Yung Shin Pharm 67
6.12.1 Yung Shin Pharm Corporation Information 67
6.12.2 Yung Shin Pharm Description and Business Overview 68
6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 68
6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio 68
6.12.5 Yung Shin Pharm Recent Developments/Updates 69
6.13 Tianjin Chase Sun Pharmaceutical 69
6.13.1 Tianjin Chase Sun Pharmaceutical Corporation Information 69
6.13.2 Tianjin Chase Sun Pharmaceutical Description and Business Overview 69
6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 70
6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio 70
6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates 71
6.14 ZISKA Pharmaceuticals 71
6.14.1 ZISKA Pharmaceuticals Corporation Information 71
6.14.2 ZISKA Pharmaceuticals Description and Business Overview 71
6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021) 72
6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio 72
6.14.5 ZISKA Pharmaceuticals Recent Developments/Updates 72
7 KETOROLAC INJECTION MANUFACTURING COST ANALYSIS 74
7.1 Ketorolac Injection Key Raw Materials Analysis 74
7.1.1 Key Raw Materials 74
7.1.2 Key Suppliers of Raw Materials 74
7.2 Proportion of Manufacturing Cost Structure 75
7.3 Ketorolac Injection Industrial Chain Analysis 76
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 77
8.1 Marketing Channel 77
8.2 Ketorolac Injection Distributors List 78
8.3 Ketorolac Injection Customers 79
9 KETOROLAC INJECTION MARKET DYNAMICS 81
9.1 Ketorolac Injection Industry Trends 81
9.2 Ketorolac Injection Growth Drivers 81
9.3 Ketorolac Injection Market Challenges 82
9.4 Ketorolac Injection Market Restraints 82
10 GLOBAL MARKET FORECAST 83
10.1 Ketorolac Injection Market Estimates and Projections by Type 83
10.1.1 Global Forecasted Sales of Ketorolac Injection by Type (2022-2027) 83
10.1.2 Global Forecasted Revenue of Ketorolac Injection by Type (2022-2027) 83
10.2 Ketorolac Injection Market Estimates and Projections by Application 84
10.2.1 Global Forecasted Sales of Ketorolac Injection by Application (2022-2027) 84
10.2.2 Global Forecasted Revenue of Ketorolac Injection by Application (2022-2027) 84
10.3 Ketorolac Injection Market Estimates and Projections by Region 85
10.3.1 Global Forecasted Sales of Ketorolac Injection by Region (2022-2027) 85
10.3.2 Global Forecasted Revenue of Ketorolac Injection by Region (2022-2027) 85
11 RESEARCH FINDINGS AND CONCLUSION 87
12 METHODOLOGY AND DATA SOURCE 88
12.1 Methodology/Research Approach 88
12.1.1 Research Programs/Design 88
12.1.2 Market Size Estimation 89
12.1.3 Market Breakdown and Data Triangulation 90
12.2 Data Source 91
12.2.1 Secondary Sources 91
12.2.2 Primary Sources 92
12.3 Author List 94
12.4 Disclaimer 94